Rankings
▼
Calendar
SRPT FY 2020 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$540M
+41.8% YoY
Gross Profit
$477M
88.3% margin
Operating Income
-$564M
-104.5% margin
Net Income
-$554M
-102.6% margin
EPS (Diluted)
$-7.11
Cash Flow
Operating Cash Flow
$107M
Free Cash Flow
$25M
Stock-Based Comp.
$108M
Balance Sheet
Total Assets
$3.0B
Total Liabilities
$2.2B
Stockholders' Equity
$762M
Cash & Equivalents
$1.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$540M
$381M
+41.8%
Gross Profit
$477M
$324M
+47.0%
Operating Income
-$564M
-$706M
+20.0%
Net Income
-$554M
-$715M
+22.5%
← Q4 2019
All Quarters
Q1 2020 →